30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a Γ-Retroviral Vector

Molecular Therapy - United States

doi 10.1016/s1525-0016(16)33634-6